Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|5|623-630

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.5, 2015-05, pp. : 623-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1395-1402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Boceprevir in liver transplant recipients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 192-197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors and clinical outcomes of pediatric liver transplant recipients with post‐transplant lymphoproliferative disease in a multi‐ethnic Asian cohort

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Posttransplant Metabolic Syndrome in the Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP‐R) Pilot Trial

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 779-785

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite